President and Chief Executive Officer

Chief Financial Officer

Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025

Soft Tissue Allograft Market to Grow at 7.5% CAGR from 2025-2029

Axogen Insider Sold Shares Worth $584,074, According to a Recent SEC Filing

Axogen, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – AXGN

Regulatory Affairs Manager, Ad Promo Review

Axogen is committed to building and maintaining a strong and gratifying company culture that fosters professional growth. The Regulatory Affairs Manager performs advertising and promotional regulatory reviews with a primary emphasis on Professional Education seminar content, ensuring materials are accurate and compliant with FDA expectations.

Regulatory Affairs Manager, Ad Promo Review (Professional Education Focus)

Director, Total Rewards & HRIS

Senior Human Resources Manager

Sr. Director, Medical Affairs Scientific Communications

Sign up with Google

Sign in with Google